EGF-ERBB signalling: towards the systems level
- PMID: 16829981
- DOI: 10.1038/nrm1962
EGF-ERBB signalling: towards the systems level
Abstract
Signalling through the ERBB/HER receptors is intricately involved in human cancer and already serves as a target for several cancer drugs. Because of its inherent complexity, it is useful to envision ERBB signalling as a bow-tie-configured, evolvable network, which shares modularity, redundancy and control circuits with robust biological and engineered systems. Because network fragility is an inevitable trade-off of robustness, systems-level understanding is expected to generate therapeutic opportunities to intercept aberrant network activation.
Similar articles
-
Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.J Biol Chem. 2006 Dec 29;281(52):40033-40. doi: 10.1074/jbc.M603168200. Epub 2006 Oct 10. J Biol Chem. 2006. PMID: 17032651
-
Binding specificities and affinities of egf domains for ErbB receptors.FEBS Lett. 1999 Mar 26;447(2-3):227-31. doi: 10.1016/s0014-5793(99)00283-5. FEBS Lett. 1999. PMID: 10214951
-
Specificity within the EGF family/ErbB receptor family signaling network.Bioessays. 1998 Jan;20(1):41-8. doi: 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V. Bioessays. 1998. PMID: 9504046 Review.
-
An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.J Biol Chem. 2000 Nov 10;275(45):35328-34. doi: 10.1074/jbc.M005399200. J Biol Chem. 2000. PMID: 10954714
-
The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology.Int J Dev Biol. 2011;55(7-9):685-96. doi: 10.1387/ijdb.113396se. Int J Dev Biol. 2011. PMID: 22161825 Review.
Cited by
-
Hirschsprung disease and more: dysregulation of ERBB2 and ERBB3.J Clin Invest. 2021 Mar 15;131(6):e146389. doi: 10.1172/JCI146389. J Clin Invest. 2021. PMID: 33720042 Free PMC article.
-
CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.Oncogene. 2017 Feb 23;36(8):1134-1144. doi: 10.1038/onc.2016.280. Epub 2016 Aug 22. Oncogene. 2017. PMID: 27546621
-
Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.PLoS One. 2012;7(5):e36170. doi: 10.1371/journal.pone.0036170. Epub 2012 May 18. PLoS One. 2012. PMID: 22623953 Free PMC article.
-
Cell-free synthesis of functional human epidermal growth factor receptor: Investigation of ligand-independent dimerization in Sf21 microsomal membranes using non-canonical amino acids.Sci Rep. 2016 Sep 27;6:34048. doi: 10.1038/srep34048. Sci Rep. 2016. PMID: 27670253 Free PMC article.
-
Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis.Front Oncol. 2024 Aug 29;14:1413674. doi: 10.3389/fonc.2024.1413674. eCollection 2024. Front Oncol. 2024. PMID: 39267829 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
